Matches in Wikidata for { <http://www.wikidata.org/entity/Q62808883> ?p ?o ?g. }
Showing items 1 to 43 of
43
with 100 items per page.
- Q62808883 description "clinical trial" @default.
- Q62808883 description "ensayu clínicu" @default.
- Q62808883 description "klinisch onderzoek" @default.
- Q62808883 description "клінічне випробування" @default.
- Q62808883 description "临床试验" @default.
- Q62808883 name "OXEL: Immune Checkpoint or Capecitabine or Combination Therapy as Adjuvant Therapy for TNBC With Residual Disease" @default.
- Q62808883 type Item @default.
- Q62808883 label "OXEL: Immune Checkpoint or Capecitabine or Combination Therapy as Adjuvant Therapy for TNBC With Residual Disease" @default.
- Q62808883 prefLabel "OXEL: Immune Checkpoint or Capecitabine or Combination Therapy as Adjuvant Therapy for TNBC With Residual Disease" @default.
- Q62808883 P1132 Q62808883-D08ED23D-0FD4-4C36-96AC-133C3367FEF8 @default.
- Q62808883 P1476 Q62808883-D455C2E4-DE93-4125-BF35-F34D3F4329B3 @default.
- Q62808883 P17 Q62808883-0057BC08-4772-4660-B4CF-E141338741BD @default.
- Q62808883 P2899 Q62808883-913D2CB5-1995-4867-B815-32A76013744E @default.
- Q62808883 P3098 Q62808883-AFF001CB-0811-4F6E-B5D7-38E00FA6CD28 @default.
- Q62808883 P31 Q62808883-52B9A920-BFDC-41D4-B472-CD195C3FF29B @default.
- Q62808883 P4844 Q62808883-06489C21-8831-4549-AE0F-096464B5757D @default.
- Q62808883 P4844 Q62808883-C8B13D6E-4BCF-44A7-A92D-8B67FC62BB8E @default.
- Q62808883 P580 Q62808883-8F41CFF8-DF25-4324-8BB9-395D95AE839C @default.
- Q62808883 P582 Q62808883-207835C1-1605-420C-867F-0C9F9CC8F2ED @default.
- Q62808883 P6099 Q62808883-2154F573-4EB2-4EF4-935D-4DFD7391C1EA @default.
- Q62808883 P6153 Q62808883-2459298F-D852-4CBF-9D8A-B64BC61B40F0 @default.
- Q62808883 P6153 Q62808883-518299F8-8A42-475B-BD43-4E67396AF624 @default.
- Q62808883 P6153 Q62808883-8A0C6874-CF92-4DD0-AEF8-6A3F627CF9EB @default.
- Q62808883 P6153 Q62808883-9468FFE0-BE43-428D-BCA3-9181D4F56DC3 @default.
- Q62808883 P8005 Q62808883-282138BA-92F9-4E14-882F-4DA5348A955E @default.
- Q62808883 P8363 Q62808883-FE7B4636-418C-4D1C-8923-A9A456106B28 @default.
- Q62808883 P1132 "+45" @default.
- Q62808883 P1476 "OXEL: A Pilot Study of Immune Checkpoint or Capecitabine or Combination Therapy as Adjuvant Therapy for Triple Negative Breast Cancer With Residual Disease Following Neoadjuvant Chemotherapy" @default.
- Q62808883 P17 Q30 @default.
- Q62808883 P2899 "+18" @default.
- Q62808883 P3098 "NCT03487666" @default.
- Q62808883 P31 Q30612 @default.
- Q62808883 P4844 Q420207 @default.
- Q62808883 P4844 Q7041828 @default.
- Q62808883 P580 "2018-05-21T00:00:00Z" @default.
- Q62808883 P582 "2021-12-01T00:00:00Z" @default.
- Q62808883 P6099 Q42824440 @default.
- Q62808883 P6153 Q131252 @default.
- Q62808883 P6153 Q333886 @default.
- Q62808883 P6153 Q5637237 @default.
- Q62808883 P6153 Q7971940 @default.
- Q62808883 P8005 Q76649708 @default.
- Q62808883 P8363 Q78089383 @default.